Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-30
DOI
10.1007/s12325-021-01732-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series
- (2021) Orly Lipsitz et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment
- (2021) Jason Ng et al. PSYCHOPHARMACOLOGY
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
- (2021) Roger S. McIntyre et al. AMERICAN JOURNAL OF PSYCHIATRY
- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
- (2020) Chadi G. Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence
- (2020) Nelson B. Rodrigues et al. Expert Opinion On Drug Safety
- A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019
- (2020) Walter S. Marcantoni et al. JOURNAL OF AFFECTIVE DISORDERS
- The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis
- (2020) Jiaqi Xiong et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
- (2020) Orly Lipsitz et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial
- (2019) Sara Costi et al. NEUROPSYCHOPHARMACOLOGY
- Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
- (2019) Jennifer L. Phillips et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
- (2019) Ella J. Daly et al. JAMA Psychiatry
- Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo–control study
- (2019) Mu-Hong Chen et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Repeat-Dose Ketamine Augmentation for Treatment-Resistant Depression with Chronic Suicidal Ideation: A Randomized, Double Blind, Placebo Controlled Trial
- (2018) Dawn F. Ionescu et al. JOURNAL OF AFFECTIVE DISORDERS
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression
- (2017) Samuel T. Wilkinson et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
- (2016) C. K. Loo et al. ACTA PSYCHIATRICA SCANDINAVICA
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
- (2016) Cristina Cusin et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Continuation phase intravenous ketamine in adults with treatment-resistant depression
- (2016) Jennifer L. Vande Voort et al. JOURNAL OF AFFECTIVE DISORDERS
- Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial
- (2016) Eric J. Lenze et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review
- (2016) Matthew D. Cooper et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression
- (2014) Le-Ben Wan et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Use of a Series of Ketamine Infusions in Two Patients With Treatment-Resistant Depression
- (2014) Michael Messer et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
- (2014) Bradley N. Gaynes et al. PSYCHIATRIC SERVICES
- Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
- (2013) Paulo R. Shiroma et al. JOURNAL OF AFFECTIVE DISORDERS
- Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
- (2013) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Comparing Effects of Ketamine and Thiopental Administration During Electroconvulsive Therapy in Patients With Major Depressive Disorder
- (2013) Abolghasem Yoosefi et al. JOURNAL OF ECT
- Serial infusions of low-dose ketamine for major depression
- (2013) Keith G Rasmussen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression
- (2012) Sarah M. Szymkowicz et al. JOURNAL OF AFFECTIVE DISORDERS
- Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study
- (2012) Lobna Ibrahim et al. NEUROPSYCHOPHARMACOLOGY
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
- (2009) Sanjay J. Mathew et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search